Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Eurocontrol Technics Ord EUCTF

"Eurocontrol Technics Group Inc is a Canada-based company involved in acquisition, development, and commercialization of security, authentication, verification and certification markets. The company through its subsidiaries is engaged in designing, manufacturing, marketing of energy-dispersive X-ray fluorescence (ED-XRF) systems, and developing technology and property that combines two-dimensional (2D) and three-dimensional (3D) image processing technology respectively."


OTCPK:EUCTF - Post by User

Post by Chutzpahon Jul 11, 2017 3:16pm
54 Views
Post# 26456930

Lorus Therapeutics (now Aptose)

Lorus Therapeutics (now Aptose)From Speechboy to Bellboy....

Was Brucey´s only public company experience before joining EUO as Gadi Gonen´s (very well paid)  BellBoy and the only thing he did there was to give speeches as IR ( they called it "Public Affairs" back then in the old days.... ) 

https://www.4-traders.com/business-leaders/W-Rowlands-063GV1-E/biography/

Mr. Rowlands was previously employed as Senior Vice President-Planning & Public Affairs by Aptose Biosciences, Inc.


Lorus Therapeutics Presents at Bio-Europe International Partnering Conference

Source Press Release
Company Aptose Biosciences
Tags Presentations & Events
Date November 18, 2003

Lorus also presents to German companies through Canadian sponsored event

Toronto, Canada -- November 18, 2003 -- Lorus  Therapeutics Inc. (“Lorus ”) announced today that Lorus  will present a review of its oncology pipeline at 2:15 p.m. on Tuesday, November 18, 2003 at Bio-Europe 2003 in Frankfurt, Germany.

Bruce Rowlands, senior advisor, will give a presentation that will highlight the company’s clinical programs, and outline the significant progress Lorus  has made during the past year. Currently,  Lorus  has one Phase I clinical trial in the US, four Phase II clinical trials in the US and Canada, and a pivotal Phase III registration clinical trial in pancreatic cancer in North America and Europe.

Lorus  will also be participating in the Canadian government sponsored partnering meeting, which presents Canadian biotechnology companies to German pharmaceutical companies to facilitate international partnership opportunities. Seventeen Canadian companies will be participating, including  Lorus .

The annual Bio-Europe Conference provides a forum where international representatives in the biotechnology, pharmaceutical, and financial sector can meet to initiate and develop partnerships. The success of Bio-Europe is based on three major components: partnering, presentations, and expert workshops and panels.

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse